Marlborough-based medical device manufacturer Boston Scientific has completed its acquisition of Valencia Technologies, a California manufacturer specializing in bladder dysfunction treatments.
The acquisition, originally announced in January, adds Valencia Technologies’ eCoin system to Boston Scientific’s portfolio, the company announced Wednesday.
The system treats an overactive bladder through a coin-sized implantable device that stimulates a nerve to help regulate communication between the brain and the bladder.Â
Boston Scientific did not disclose the financial terms of the transaction, spokesperson Nate Gilbraith said in an email to WBJ.
The eCoin system gained U.S. Food and Drug Administration approval in 2022, with 68% of users reporting at least a 50% decrease in their urinary incontinence symptoms.
Nearly 30 million U.S. adults age 40 and older experience overactive bladder, according to Boston Scientific.
The completed transaction comes as Boston Scientific is in the midst of an acquisition streak. In January, the manufacturer announced it would spend $14.5 billion to acquire Penumbra, a California-based healthcare company.Â
In October, the firm said it would purchase Nalu Medical, a California-based medical technology firm, for $533 million. Â
Founded in 1979, Boston Scientific manufactures medical devices used to treat a range of conditions, including urological, cardiovascular, digestive and neurological diseases. With 2,800 local employees, the company is Central Massachusetts’ second-largest manufacturer, according to WBJ Research Department data.
Mica Kanner-Mascolo is a staff writer at Worcester Business Journal, who primarily covers the healthcare, manufacturing, and higher education industries.
